What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Epilepsy
- Gene
Erik Taubøll mostly deals with Internal medicine, Epilepsy, Endocrinology, Endocrine system and Hormone.
His research in Internal medicine intersects with topics in Anatomy and Cardiology.
His work on Lamotrigine is typically connected to Catamenial epilepsy as part of general Epilepsy study, connecting several disciplines of science.
The study incorporates disciplines such as Anticonvulsant and Analysis of variance in addition to Endocrinology.
His study focuses on the intersection of Endocrine system and fields such as Carbamazepine with connections in the field of Physiology, Semen quality, Libido, Potency and Body mass index.
His Hormone research includes elements of Side effect and Infertility.
His most cited work include:
- Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy. (156 citations)
- Altered ovarian function and cardiovascular risk factors in valproate-treated women (117 citations)
- New SCN5A mutation in a SUDEP victim with idiopathic epilepsy. (109 citations)
What are the main themes of his work throughout his whole career to date?
Erik Taubøll mainly investigates Epilepsy, Internal medicine, Endocrinology, Pediatrics and Lamotrigine.
He works in the field of Epilepsy, namely Carbamazepine.
His Internal medicine research incorporates elements of Cardiology, Valproic Acid and Levetiracetam.
His Endocrinology research focuses on Anticonvulsant and how it connects with Central nervous system disease.
His studies deal with areas such as Gynecology, Menopause, Cause of death and Menstrual cycle as well as Pediatrics.
His Endocrine system study integrates concerns from other disciplines, such as Sex hormone-binding globulin and Animal studies.
He most often published in these fields:
- Epilepsy (100.54%)
- Internal medicine (63.98%)
- Endocrinology (37.10%)
What were the highlights of his more recent work (between 2017-2021)?
- Epilepsy (100.54%)
- Internal medicine (63.98%)
- Cohort (12.90%)
In recent papers he was focusing on the following fields of study:
Erik Taubøll mainly focuses on Epilepsy, Internal medicine, Cohort, Status epilepticus and Electroencephalography.
His Epilepsy research incorporates themes from Long QT syndrome and Pediatrics.
His Internal medicine study combines topics in areas such as Cardiology, Drug Resistant Epilepsy, Atkins diet, Ketogenic diet and Carbamazepine.
His study in Atkins diet is interdisciplinary in nature, drawing from both Thyroid function, Endocrinology, Adverse effect and Ketosis.
His work deals with themes such as Biomarker and Levetiracetam, which intersect with Carbamazepine.
His biological study spans a wide range of topics, including Area under the curve, Epidemiology, Level of consciousness, Valproic Acid and Brain damage.
Between 2017 and 2021, his most popular works were:
- Effect of modified Atkins diet in adults with drug-resistant focal epilepsy: A randomized clinical trial. (22 citations)
- Effect of modified Atkins diet in adults with drug-resistant focal epilepsy: A randomized clinical trial. (22 citations)
- Ca2+ Signals in Astrocytes Facilitate Spread of Epileptiform Activity. (20 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
Epilepsy, In patient, Atkins diet, Ketogenic diet and Internal medicine are his primary areas of study.
His Epilepsy research is multidisciplinary, relying on both Anesthesia, Long QT syndrome, Pediatrics and Sudden cardiac death.
Erik Taubøll integrates many fields, such as In patient and engineering, in his works.
The various areas that Erik Taubøll examines in his Atkins diet study include Drug Resistant Epilepsy, Clinical endpoint, Randomized controlled trial and Interquartile range.
His research integrates issues of Ketosis, Lamotrigine, Gastroenterology and Zonisamide, Topiramate in his study of Ketogenic diet.
His Internal medicine study combines topics from a wide range of disciplines, such as Carbamazepine and Oxcarbazepine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
